Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alissa Visram

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|April 3, 2022
Success of the autologous stem cell boost after autologous graft failure in multiple myeloma and AL amyloidosisJoselle Cook, Wilson I Gonsalves, Morie A Gertz, et al.
Blood Cancer Journal|July 20, 2023
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysisArleigh McCurdy, Hira Mian, Richard LeBlanc, et al.
Leukemia|November 12, 2021
Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosisAlissa Visram, Celine Vachon, Linda B Baughn, et al.
Leukemia|June 17, 2024
Correction: Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosisAlissa Visram, Celine Vachon, Linda B Baughn, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 4, 2020
Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma PatientsAbdullah S Al Saleh, Harsh V Parmar, Alissa Visram, et al.
Blood Advances|April 12, 2022
Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman-Mazur, Alissa Visram, Prashant Kapoor, et al.
Leukemia & Lymphoma|July 15, 2021
Treatment and outcome of newly diagnosed multiple myeloma patients > 75 years old: a retrospective analysisAbdullah S Al Saleh, Alissa Visram, Harsh Parmar, et al.
Cancer Medicine|October 6, 2020
Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatmentIuliana Vaxman, Abdullah S Al Saleh, Shaji Kumar, et al.
Bone Marrow Transplantation|July 6, 2020
Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantationAbdullah S Al Saleh, Harsh V Parmar, Iuliana Vaxman, et al.
Leukemia|February 24, 2021
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patientsAlissa Visram, Iuliana Vaxman, Abdullah S Al Saleh, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|April 3, 2022
Success of the autologous stem cell boost after autologous graft failure in multiple myeloma and AL amyloidosisJoselle Cook, Wilson I Gonsalves, Morie A Gertz, et al.
Blood Cancer Journal|July 20, 2023
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysisArleigh McCurdy, Hira Mian, Richard LeBlanc, et al.
Leukemia|November 12, 2021
Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosisAlissa Visram, Celine Vachon, Linda B Baughn, et al.
Leukemia|June 17, 2024
Correction: Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosisAlissa Visram, Celine Vachon, Linda B Baughn, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 4, 2020
Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma PatientsAbdullah S Al Saleh, Harsh V Parmar, Alissa Visram, et al.
Blood Advances|April 12, 2022
Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman-Mazur, Alissa Visram, Prashant Kapoor, et al.
Leukemia & Lymphoma|July 15, 2021
Treatment and outcome of newly diagnosed multiple myeloma patients > 75 years old: a retrospective analysisAbdullah S Al Saleh, Alissa Visram, Harsh Parmar, et al.
Cancer Medicine|October 6, 2020
Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatmentIuliana Vaxman, Abdullah S Al Saleh, Shaji Kumar, et al.
Bone Marrow Transplantation|July 6, 2020
Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantationAbdullah S Al Saleh, Harsh V Parmar, Iuliana Vaxman, et al.
Leukemia|February 24, 2021
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patientsAlissa Visram, Iuliana Vaxman, Abdullah S Al Saleh, et al.
Pageof 8